MedTrace Logo

Effects of the Multispecies Probiotic Ecologic Barrier in IBS Patients With Upper GI Symptoms and Anxiety, Depression, or Stress

NCT07656623 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-06-18

No results posted yet for this study

Summary

The aim of this clinical trial is to find out whether Ecologic Barrier is effective in supporting the treatment of irritable bowel syndrome (IBS) in adults. The main questions that this trial aims to answer are:

* Does Ecologic Barrier help improve IBS severity when added to standard IBS treatment?
* Does Ecologic Barrier help improve symptoms of anxiety, depression, and stress in patients with IBS?
* Does Ecologic Barrier help improve upper gastrointestinal symptoms when added to standard IBS treatment?
* What adverse events may occur when using Ecologic Barrier? The researchers will compare a group receiving standard symptom-based treatment with another group receiving standard treatment plus Ecologic Barrier.

Participants will:

* Receive IBS treatment for 2 months, with Ecologic Barrier added during either the first month or the second month, depending on random assignment.
* Attend a follow-up visit after 1 month of treatment.
* Take part in interviews about IBS severity, symptom improvement, adverse events, and symptoms of depression and anxiety at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.

Conditions

  • Irritable Bowel Syndrome With Diarrhea

Interventions

DIETARY_SUPPLEMENT

Ecologic Barrier

Ecologic Barrier will be added to the standard treatment regimen during the first month of treatment.

DIETARY_SUPPLEMENT

Ecologic Barrier

Ecologic Barrier will be added to the standard treatment regimen during the second month of treatment.

Sponsors & Collaborators

  • Institute of Gastroenterology and Hepatology, Vietnam

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07656623 on ClinicalTrials.gov